Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP281033.RAWo6vAneZ2OyYZoF71pZpxMrZoDkqtBM64ff2VpN8tQU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP281033.RAWo6vAneZ2OyYZoF71pZpxMrZoDkqtBM64ff2VpN8tQU130_assertion type Assertion NP281033.RAWo6vAneZ2OyYZoF71pZpxMrZoDkqtBM64ff2VpN8tQU130_head.
- NP281033.RAWo6vAneZ2OyYZoF71pZpxMrZoDkqtBM64ff2VpN8tQU130_assertion description "[We investigated if the MET-activating point mutation Y1253D influences clinical outcomes in patients with advanced squamous cell carcinoma of the head and neck (HNSCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP281033.RAWo6vAneZ2OyYZoF71pZpxMrZoDkqtBM64ff2VpN8tQU130_provenance.
- NP281033.RAWo6vAneZ2OyYZoF71pZpxMrZoDkqtBM64ff2VpN8tQU130_assertion evidence source_evidence_literature NP281033.RAWo6vAneZ2OyYZoF71pZpxMrZoDkqtBM64ff2VpN8tQU130_provenance.
- NP281033.RAWo6vAneZ2OyYZoF71pZpxMrZoDkqtBM64ff2VpN8tQU130_assertion SIO_000772 19639388 NP281033.RAWo6vAneZ2OyYZoF71pZpxMrZoDkqtBM64ff2VpN8tQU130_provenance.
- NP281033.RAWo6vAneZ2OyYZoF71pZpxMrZoDkqtBM64ff2VpN8tQU130_assertion wasDerivedFrom befree-20140225 NP281033.RAWo6vAneZ2OyYZoF71pZpxMrZoDkqtBM64ff2VpN8tQU130_provenance.
- NP281033.RAWo6vAneZ2OyYZoF71pZpxMrZoDkqtBM64ff2VpN8tQU130_assertion wasGeneratedBy ECO_0000203 NP281033.RAWo6vAneZ2OyYZoF71pZpxMrZoDkqtBM64ff2VpN8tQU130_provenance.